Neoplasia/BPH

	An integrated restricted mean survival time-based evaluation of efficacy, toxicity, and cost in first-line immunotherapy regimens for metastatic renal cell carcinoma. Urol Oncol Ishiyama Y, Venkatesh A, McGrath J, Rosales RDR, Kanumuambidi JP, Bandyk M, Balaji KC. PMID: 41991383 [PubMed - as supplied by publisher]
	Persistent suicide risk in survivors of testicular cancer: A population-based cohort study. Urol Oncol Cheng KW, Farkouh A, Castillo JK, Jhang D, Song S, Zaki P, Shin J, Hofmann M, Douglawi A, Hu B, Ruckle H, Alsyouf M. PMID: 41991382 [PubMed - as supplied by publisher]
	Novel immunotherapies for prostate cancer. Urol Oncol Mo G, Narayan V. PMID: 41991381 [PubMed - as supplied by publisher]
	Preclinical and First-in-Human Study of Carbonic Anhydrase IX-Targeting Theranostic Pair, [(68)Ga]Ga/[(177)Lu]Lu-NYM096, in Clear Cell Renal Cell Carcinoma. J Nucl Med Wang J, Yan X, Liu M, Yang X, Zheng G, Li X, Cheng Y, Bai C, Zhang Y, Zhu W, Huo L. PMID: 41991341 [PubMed - as supplied by publisher]
	Circulating Tumor DNA Genomic Profiling in (223)Ra-Treated Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study. J Nucl Med Shiota M, Fujiwara M, Sumiyoshi T, Enokida H, Kamba T, Igawa T, Masumori N, Uemura H, Kamoto T, Higashijima K, Mitsunari K, Uemura H, Kobayashi T, Akamatsu S, Tokunaga S, Isoda T, Ishigami K, Eto M. PMID: 41991340 [PubMed - as supplied by publisher]
	Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study. BMJ Open Re C, Stimpson G, Stewart GD, Bromley J, Archer S, Batley C, Godoy A, Usher-Smith J, Harrison H. PMID: 41991271 [PubMed - indexed for MEDLINE]
	MÃ¼llerian duct cyst and prostate adenocarcinoma in a young adult. BMJ Case Rep Filippidis I, Mantzoukidou N, Evangelou K, Vouros I, Sakalis V. PMID: 41991234 [PubMed - indexed for MEDLINE]
	Multiplexed P21/MCM-2 detection predicts relapse and may identify tyrosine kinase inhibitor-resistant patients in clear cell renal cell carcinoma. Cancer Res Commun Abdullah H, Um IH, Stewart GD, Jeong CW, Kwak C, Moon KC, Laird A, Frangou E, Eisen T, Meade A, Harrison DJ. PMID: 41990272 [PubMed - as supplied by publisher]
	Artificial Intelligence Design for Race-Based Prostate Cancer Stage Classification With Multilayer Perceptron: Feature Selection Optimization Approach. JMIR Form Res Mulia A, Agustriawan D, Overbeek M, Widjaja M, Kurniawan V, Syechlo J, Ahmad MI, Sathipati SY, Kurubanjerdjit N. PMID: 41989963 [PubMed - indexed for MEDLINE]
	Clinical Outcomes in Bacillus Calmette-GuÃ©rin-Exposed Non-Muscle-Invasive Bladder Cancer. JAMA Netw Open Giatsoglou M, Chatzistavrou D, Sopczynski JM, Feng G, Li R. PMID: 41989781 [PubMed - indexed for MEDLINE]
	Ongoing and completed clinical trials on prostate cancer screening using MRI. Eur Radiol Wallström J, Jäderling F, Langkilde F, Arnsrud Godtman R, Bratt O, Thimansson E. PMID: 41989465 [PubMed - as supplied by publisher]
	Primary Prostatic Alveolar Rhabdomyosarcoma in Adult, a Diagnostic Pitfall: Report of an Extremely Rare Tumor. Int J Surg Pathol Mitra S, Choube A, Ratnaparkhi C, Pande S. PMID: 41989357 [PubMed - as supplied by publisher]
	Micro-ultrasonography- vs MRI-targeted biopsy in prostate cancer: Updated systematic review and meta-analysis. BJU Int Micheleto JPC, Suzuki TÁ, Santos LA, Sales LP, Lopes RI, Martins BM, Aguiar Melão BVL, Cordeiro MD, Sharour W, Shabana W, Nahas WC, Ribeiro Filho LA, Suartz CV. PMID: 41989063 [PubMed - as supplied by publisher]
	Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617. Cancer Gerke MB, Marra A, Liu Y, Bedmutha A, Brown JT, Nazha B, Berchuck JE, Parikh RB, Ahmed S, Ciuro JA, Hartman C, McClintock GR, Caulfield S, Kucuk O, Carthon BC, Schuster DM, Muzahir S, Bilen MA. PMID: 41989013 [PubMed - indexed for MEDLINE]
	Clinically Localized Prostate Cancer: AUA/ASTRO Guideline Amendment (2026). J Urol Eastham JA, Barocas DA, Chu CE, Morgans AK, Rodrigues G, Kirkby E, Pak LJ, Patel S. PMID: 41988960 [PubMed - as supplied by publisher]
	Urine-Based FTIR Spectroscopy and Machine Learning Enable Non-Invasive Kidney Cancer Detection. J Biophotonics Mitura P, Odrzywolski A, Szyszkowska O, Gumbarewicz E, Kuliniec I, Godzisz M, Jad, Depciuch J. PMID: 41988812 [PubMed - indexed for MEDLINE]
	Chronic kidney disease as an active driver of digestive tract tumors: mechanistic insights and emerging management strategies. Front Cell Dev Biol Dong H, Cao H, Gong Y, Zhao Z, Wang K, Zhang X, Zhang F. PMID: 41988382 [PubMed]
	Evolving Treatments and Resistance Mechanisms in Prostate Cancer Therapeutics. ACS Pharmacol Transl Sci Sai Rishma Reddy GSV, Kumar A, Sharma NK, Samanta K, Pramanik D, Karampudi NBR, Kar P. PMID: 41988377 [PubMed]
	A case report of cerebral vasculitis induced by ipilimumab with nivolumab in a patient with metastatic renal cell carcinoma. Front Immunol Palacka P, Málek T, Makovník M, Felediová R, Rychlý B, Kolníková G. PMID: 41988182 [PubMed - indexed for MEDLINE]
	Predictors of pathological upstaging to pT3a after nephrectomy for cT1 renal tumors: a systematic review and meta-analysis. Front Oncol Ye Y, Bai J, Ye Y, Lin B, Zou G, Huang J, Zheng C, Qiu Q, Zhong D, Lin J, Chen J, Cai W, Zhu S. PMID: 41988130 [PubMed]

Articles 1 - 20 / 187117

Page 1 of 9356



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy